Research theme for competitive and other funds (6):
2022 - 2025 Development of a new treatment method for repairing intestinal epithelial function of inflammatory bowel disease by human pulp MSC-conditioned medium
2018 - 2021 Inhibition of pulmonary fibrosis by mesenchymal stem cells through IL-27 and its clinical application
2017 - 2020 Therapeutic effect of mesenchymal stem cells by anti-inflammatory cytokinesIL-27 and IL-35
2014 - 2018 Study of possibility of discrimination of personae using biological censors
2007 - 2012 接着分子をターゲットとした治療薬の創製
2007 - 2012 New drug development for cell adhesion molecule-targeting therapy
Show all
Papers (23):
Yuma Furusaka, Shinya Inoue, Izuru Mizoguchi, Hideaki Hasegawa, Yasuhiro Katahira, Aruma Watanabe, Eri Sakamoto, Ami Sekine, Satomi Miyakawa, Tomohiro Umezu, et al. Potent antitumor effects of the conditioned medium of bone marrow-derived mesenchymal stem cells via IGFBP -4. Cancer Science. 2023
Izuru Mizoguchi, Yukino Chiba, Hideaki Hasegawa, Mio Ohashi, Mingli Xu, Toshiyuki Owaki, Takayuki Yoshimoto. A Novel Role for Epstein-Barr Virus-Induced Gene 3 as An Intracellular Molecule That Enhances IL-23 Receptor Expression by Binding to Calnexin and IL-23 Receptor. CYTOKINE. 2017. 100. 48-49